# Asim Roy

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/asim-roy/

## Facts

| Field | Value |
| --- | --- |
| Citations | 302 |
| Field | Sleep and Wakefulness Research |
| h-index | 9 |
| i10-index | 9 |
| Last Known Institution | Sleep Management Institute |
| OpenAlex ID | https://openalex.org/A5112958820 |
| Works | 42 |

## Researcher papers

- [Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy](https://scholariq.org/papers/once-nightly-sodium-oxybate-ft218-demonstrated-improvement-of-symptoms-in-a/)
- [Update on the treatment of idiopathic hypersomnia: Progress, challenges, and expert opinion](https://scholariq.org/papers/update-on-the-treatment-of-idiopathic-hypersomnia-progress-challenges-and-expert/)
- [Isolated Cataplexy and REM Sleep Behavior Disorder After Pontine Stroke](https://scholariq.org/papers/isolated-cataplexy-and-rem-sleep-behavior-disorder-after-pontine-stroke-2/)
- [Isolated cataplexy and REM sleep behavior disorder after pontine stroke.](https://scholariq.org/papers/isolated-cataplexy-and-rem-sleep-behavior-disorder-after-pontine-stroke/)
- [Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical trial](https://scholariq.org/papers/efficacy-and-safety-of-tonic-motor-activation-tomac-for-medication-refractory/)
- [Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study](https://scholariq.org/papers/long-term-efficacy-and-safety-of-tonic-motor-activation-for-treatment-of/)
- [Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial](https://scholariq.org/papers/adjunctive-tonic-motor-activation-enables-opioid-reduction-for-refractory/)
- [Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial](https://scholariq.org/papers/efficacy-of-once-nightly-sodium-oxybate-ft218-in-narcolepsy-type-1-and-type-2/)
- [Stevens-Johnson Syndrome After Armodafinil Use](https://scholariq.org/papers/stevens-johnson-syndrome-after-armodafinil-use/)
- [Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations](https://scholariq.org/papers/dosing-optimization-of-low-sodium-oxybate-in-narcolepsy-and-idiopathic/)

## Researcher topics

- [Sleep and Wakefulness Research](https://scholariq.org/topics/sleep-and-wakefulness-research/)
- [Restless Legs Syndrome Research](https://scholariq.org/topics/restless-legs-syndrome-research/)
- [Sleep and related disorders](https://scholariq.org/topics/sleep-and-related-disorders/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Sleep and Work-Related Fatigue](https://scholariq.org/topics/sleep-and-work-related-fatigue/)

## Researcher university

- [Sleep Management Institute](https://scholariq.org/institutions/sleep-management-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.